Population PK‐PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197

Por De Buck, S, Hueber, W, Vitaliti, A, Straube, F, Emotte, C, Bruin, G, Woessner, R
Publicado no CPT Pharmacometrics Syst Pharmacol (2015)